000 | 01561nam a22003617a 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20250120154254.0 | ||
006 | m|||||o||d| 00| 0 | ||
007 | cr || auc||a|a | ||
008 | 230420s2023 caua sb 001 0 eng d | ||
020 |
_a9780520388727 _qeBook |
||
040 | _cQCPL | ||
082 | _a338.4761510973 | ||
100 | 1 |
_98227 _aRoy, Victor _eauthor |
|
245 | 1 | 0 |
_aCapitalizing a cure _b: how finance controls the price and value of medicines _c/ Victor Roy |
264 | 1 |
_aOakland, California : _bUniversity of California Press, _c[2023] |
|
300 |
_a1 online resource (200 pages) : _billustrations |
||
336 |
_2rdacontent _atext |
||
337 |
_2rdamedia _acomputer |
||
338 |
_2rdacarrier _aonline resource |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aIntroduction : the politics of drug pricing and the value of a cure | |
505 | 0 | _aCapitalizing science : public knowledge into pharmaceutical assets | |
505 | 0 | _aCapitalizing drugs : shareholder power and the cannibalizing company | |
505 | 0 | _aCapitalizing health : the struggle over value and treatment access | |
505 | 0 | _aFrom financialization to public purpose for health | |
505 | 0 | _aConclusion : reckoning with pharmaceutical value in crisis times | |
650 |
_aPharmaceutical industry _xEconomic aspects _zUnited States |
||
650 |
_aDrugs _xPrices _zUnited States |
||
650 |
_aDrug development _xEconomic aspects _zUnited States |
||
856 | _uhttps://drive.google.com/file/d/1CusfxdClLeAhx38NpBvFAbeOnoKb9SHE/view?usp=drive_link | ||
942 |
_2ddc _cEBOOK |
||
999 |
_c18875 _d18874 |